Dox-pVEC-gHo (Dox- gHoPe2)

General Information


DRACP ID  DRACP05362

Peptide Name   Dox-pVEC-gHo (Dox- gHoPe2)

Sequence  CLLIILRRRIRKQAHAHSKNHQQQNPHQPPM

Sequence Length  31

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Succinimidyl-4-(N-mal-eimidomethyl) cyclohexane-1-carboxylate (SMCC)

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C161H270N60O40S2

Absent amino acids  DEFGTVWY

Common amino acids  Q

Mass  428572

Pl  12.52

Basic residues  10

Acidic residues  0

Hydrophobic residues  8

Net charge  10

Boman Index  -9703

Hydrophobicity  -115.48

Aliphatic Index  81.94

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23350661

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2043

DRACP is developed by Dr.Zheng's team.